EOMES high PD-1 high CD103 + effector memory CD8 T cells in malignant pleural effusion: a distinct subset implicated in anti-tumor immunity and immunotherapeutic response

Malignant pleural effusion (MPE) is a frequent complication of advanced cancers and is associated with poor prognosis, including in patients receiving immune checkpoint inhibitors (ICIs). We characterized T-cell populations in pleural effusion samples from patients with malignant (n = 34) and benign (n = 11) conditions using multiparametric flow cytometry and cytokine analysis, complemented by reanalysis of publicly available single-cell RNA sequencing datasets. MPE was characterized by enrichment of CD8⁺ effector memory (EM) T cells, including a distinct EOMEShighPD-1highCD103+ population. This subset exhibited increased expression of tissue residency-associated markers, including CD69 and CXCR6, together with increased granzyme B and Ki-67 expression and enhanced IFN-γ production following CD3/CD28 stimulation. Despite high PD-1 expression, it did not exhibit a coordinated increase in exhaustion-associated markers. Single-cell transcriptomic analyzes of breast cancer- and lung adenocarcinoma-associated MPE datasets identified related HLA-II⁺ CD8⁺ T-cell states with effector-associated features, and increased HLA-DR protein expression was confirmed by flow cytometry. Among patients receiving ICIs, this population was more abundant in those showing improvement in malignant pleural effusion, whose overall responses ranged from stable disease to partial response, whereas patients without pleural effusion improvement had progressive disease. These findings identify a tissue residency-associated, HLA-II-expressing CD8⁺ EM T-cell population with effector-associated features in MPE and suggest its potential clinical relevance during ICI therapy.

Authors

Institutions

Publication Details

Journal
OncoImmunology
Published
2026-11-18
DOI
https://doi.org/10.1080/2162402x.2026.2764481
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

EOMES high PD-1 high CD103 + effector memory CD8 T cells in malignant pleural effusion: a distinct subset implicated in anti-tumor immunity and immunotherapeutic response

Eui‐Cheol Shin, Chaeuk Chung, Da Hyun Kang, Duk Ki Kim et al.
2 links
OncoImmunology
Cancer Immunotherapy and Biomarkers
article

EOMES high PD-1 high CD103 + effector memory CD8 T cells in malignant pleural effusion: a distinct subset implicated in anti-tumor immunity and immunotherapeutic response

Eui‐Cheol Shin, Chaeuk Chung, Da Hyun Kang, Duk Ki Kim, Pureum Sun, Dahye Lee, Nayoung Kim, Junyoung O. Park, Jeong Eun Lee, Song-I Lee, Hye Sook Han
article en

Abstract

Malignant pleural effusion (MPE) is a frequent complication of advanced cancers and is associated with poor prognosis, including in patients receiving immune checkpoint inhibitors (ICIs). We characterized T-cell populations in pleural effusion samples from patients with malignant (n = 34) and benign (n = 11) conditions using multiparametric flow cytometry and cytokine analysis, complemented by reanalysis of publicly available single-cell RNA sequencing datasets. MPE was characterized by enrichment of CD8⁺ effector memory (EM) T cells, including a distinct EOMEShighPD-1highCD103+ population. This subset exhibited increased expression of tissue residency-associated markers, including CD69 and CXCR6, together with increased granzyme B and Ki-67 expression and enhanced IFN-γ production following CD3/CD28 stimulation. Despite high PD-1 expression, it did not exhibit a coordinated increase in exhaustion-associated markers. Single-cell transcriptomic analyzes of breast cancer- and lung adenocarcinoma-associated MPE datasets identified related HLA-II⁺ CD8⁺ T-cell states with effector-associated features, and increased HLA-DR protein expression was confirmed by flow cytometry. Among patients receiving ICIs, this population was more abundant in those showing improvement in malignant pleural effusion, whose overall responses ranged from stable disease to partial response, whereas patients without pleural effusion improvement had progressive disease. These findings identify a tissue residency-associated, HLA-II-expressing CD8⁺ EM T-cell population with effector-associated features in MPE and suggest its potential clinical relevance during ICI therapy.

OncoImmunologyVol. 15(1)
Korea Advanced Institute of Science and Technology (KR), University of California, Los Angeles (US), Chungbuk National University (KR), Chungnam National University (KR), Chungnam National University Hospital (KR), Chungbuk National University Hospital (KR)
Chungnam National University, Korea Health Industry Development Institute, National Research Foundation of Korea, Chungnam National University Hospital, Ministry of Science and ICT, South Korea
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon